Pivotal trial of Nitric Oxide-Inhalation (NO) in the patients with Mycobacterium Abscessus Complex (MABSC).
Phase of Trial: Phase III
Latest Information Update: 24 Jan 2018
At a glance
- Drugs Nitric oxide (Primary)
- Indications Mycobacterium avium complex infections
- Focus Registrational; Therapeutic Use
- Sponsors AIT
- 24 Jan 2018 Planned initiation date changed from 1 Jul 2017 to 1 Jul 2018.
- 29 Nov 2017 New trial record
- 27 Nov 2017 According to an AIT media release, this trial is expected to begin in the second half of 2018.